Ohmann Christian, Imhof Michael, Ruppert Christian, Janzik Ulf, Vogt Christoph, Frieling Thomas, Becker Klaus, Neumann Frank, Faust Stephan, Heiler Klaus, Haas Klaus, Jurisch Rainer, Wenzel Ernst-Günter, Normann Stefan, Bachmann Oliver, Delgadillo Jorge, Seidel Florian, Franke Claus, Lüthen Reinhard, Yang Qin, Reinhold Christian
Koordinierungszentrum für Klinische Studien, Heinrich-Heine-Universität.
Scand J Gastroenterol. 2005 Aug;40(8):914-20. doi: 10.1080/00365520510015809.
Despite the introduction of effective medical treatment of peptic ulcer disease, bleeding is still a frequent complication. The aim of this study was to investigate whether the incidence and the risk profile of peptic ulcer haemorrhage have changed within a 10-year period.
In a prospective epidemiological and observational study the incidence and risk profile of peptic ulcer haemorrhage in Düsseldorf, Germany were compared between two time periods (period A: 1.3.89-28.2.90 and period B: 1.4.99-31.3.2000), involving nine hospitals with both surgical and medical departments. Patients with proven peptic ulcer haemorrhage at endoscopy or operation were included in the study; those with bleeding under defined severe stress conditions were excluded.
No differences in bleeding ulcer incidence were observed between periods A and B (51.4 per 100,000 person-years versus 48.7), or for duodenal ulcer (24.9 versus 25.7) or for gastric ulcer bleeding (26.5 versus 23.0). A marked increase in incidence rates was observed with increasing age. In period B, patients with bleeding ulcers were older (56% versus 41% 70 years or older), were usually taking non-steroidal anti-inflammatory drugs (NSAIDs) (45% versus 27%) and were less likely to have a history of ulcer (25% versus 59%) compared with patients in period A.
The persisting high incidence of peptic ulcer disease is a superimposing of two trends: a higher incidence in the growing population of elderly patient with a higher intake of NSAIDs and a lower incidence among younger patients due to a decrease in incidence and improved medical treatment.
尽管已引入消化性溃疡疾病的有效药物治疗,但出血仍是常见并发症。本研究旨在调查消化性溃疡出血的发生率和风险状况在10年期间是否发生了变化。
在一项前瞻性流行病学观察研究中,比较了德国杜塞尔多夫两个时间段(A期:1989年3月1日至1990年2月28日;B期:1999年4月1日至2000年3月31日)消化性溃疡出血的发生率和风险状况,涉及9家设有外科和内科的医院。在内镜检查或手术中证实为消化性溃疡出血的患者纳入研究;排除在明确的严重应激条件下出血的患者。
A期和B期之间,出血性溃疡的发生率没有差异(分别为每10万人年51.4例和48.7例),十二指肠溃疡(分别为24.9例和25.7例)或胃溃疡出血(分别为26.5例和23.0例)也无差异。随着年龄增长,发病率显著上升。与A期患者相比,B期出血性溃疡患者年龄更大(70岁及以上者分别为56%和41%),通常服用非甾体抗炎药(NSAIDs)(分别为45%和27%),且溃疡病史的可能性较小(分别为25%和59%)。
消化性溃疡疾病持续高发是两种趋势叠加的结果:在服用NSAIDs较多的老年患者人群中发病率较高,而在年轻患者中由于发病率下降和医疗改善发病率较低。